Multiple myeloma cells catalyze hepatocyte growth factor (HGF) activation by secreting the serine protease HGF-activator
- 1 October 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 104 (7) , 2172-2175
- https://doi.org/10.1182/blood-2003-12-4386
Abstract
Multiple myeloma (MM) is a common hematologic neoplasm consisting of malignant plasma cells, which expand in the bone marrow. A potential key signal in the evolution of MM is hepatocyte growth factor (HGF), which acts as a potent paracrine and/or autocrine growth factor and survival factor for MM cells. Proteolytic conversion of HGF into its active form is a critical limiting step in HGF/MET signaling. Here, we show that malignant MM plasma cells convert HGF into its active form and secrete HGF-activator (HGFA), a serine protease specific for HGF activation. By using serine protease inhibitors and neutralizing antibodies, we demonstrate that HGFA produced by the MM cells is responsible for their ability to catalyze HGF activation. We, therefore, suggest that autocatalyzation of HGF conversion by MM cells is an important step in HGF/MET-induced myeloma growth and survival, which may have implications for the management of this incurable form of cancer. (Blood. 2004;104:2172-2175)Keywords
This publication has 23 references indexed in Scilit:
- The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myelomaLeukemia, 2003
- HGF/SF‐met signaling in the control of branching morphogenesis and invasionJournal of Cellular Biochemistry, 2003
- Molecular mechanisms of novel therapeutic approaches for multiple myelomaNature Reviews Cancer, 2002
- Scatter-factor and semaphorin receptors: cell signalling for invasive growthNature Reviews Cancer, 2002
- Multiple myeloma: evolving genetic events and host interactionsNature Reviews Cancer, 2002
- Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cellsBlood, 2002
- Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myelomaBlood, 2002
- The hepatocyte growth factor/ met pathway in development, tumorigenesis, and B-cell differentiationPublished by Elsevier ,2000
- Hepatocyte Growth Factor Is Constitutively Produced by Human Bone Marrow Stromal Cells and Indirectly Promotes HematopoiesisBlood, 1997
- Concomitant Expression of Hepatocyte Growth Factor/Scatter Factor and the Receptor c-MET in Human Myeloma Cell LinesJournal of Biological Chemistry, 1996